Table 4.
Changes of immune parameters from the beginning of the study to the last follow-up
| Variable | Multitarget | IVCY | Difference (95% CI) | P |
|---|---|---|---|---|
| Negative conversion ratio of Anti-dsDNA | 6/12 (50.0%) | 4/12 (33.3%) | 16.7% (−22.2% to 55.5%) | 0.680 |
| Normalization rate of serum C3 | 11/20 (55.0%) | 8/19 (42.1%) | 12.9% (−18.2% to 44.0%) | 0.527 |